ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 222 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $339,174 | -22.3% | 9,514 | +0.6% | 0.01% | -16.7% |
Q2 2023 | $436,436 | +42.5% | 9,461 | +23.9% | 0.01% | +50.0% |
Q1 2023 | $306,244 | -14.3% | 7,637 | -1.0% | 0.00% | -33.3% |
Q4 2022 | $357,436 | +35.9% | 7,715 | +21.3% | 0.01% | +20.0% |
Q3 2022 | $263,000 | -31.7% | 6,361 | -1.3% | 0.01% | -37.5% |
Q2 2022 | $385,000 | -7.0% | 6,446 | +13.2% | 0.01% | +14.3% |
Q1 2022 | $414,000 | -13.9% | 5,696 | -0.4% | 0.01% | -12.5% |
Q4 2021 | $481,000 | -5.1% | 5,718 | +1.7% | 0.01% | -20.0% |
Q3 2021 | $507,000 | -8.2% | 5,621 | -3.0% | 0.01% | 0.0% |
Q2 2021 | $552,000 | +117.3% | 5,794 | +215.2% | 0.01% | +66.7% |
Q4 2020 | $254,000 | +23.9% | 1,838 | -30.0% | 0.01% | +20.0% |
Q2 2020 | $205,000 | – | 2,627 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |